![Pritesh Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then served as the Chief Growth Officer at NovoCure Ltd. from 2022 to 2024.
Dr. Shah holds a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Eerdere bekende functies van Pritesh Shah
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVOCURE LIMITED | Corporate Officer/Principal | 01-01-2024 |
| OSI PHARMACEUTICALS, INC. | Verkoop & Marketing | - |
Opleiding van Pritesh Shah
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Kies MarketScreener 
